07-18-2024  6:28 am   •   PDX and SEA Weather

By The Skanner News | The Skanner News
Published: 12 June 2023

Salem, Ore. – Attorney General Ellen Rosenblum has announced the final acceptance of $17.3 billion in opioid agreements by drug makers Teva and Allergan and pharmacies CVS and Walgreens. Oregon is anticipated to receive nearly $219.4 million over the next 15 years, with funds starting to arrive to state and local governments by the end of 2023. 

The Oregon Health Authority now estimates that five Oregonians die every week from opioid-related overdoses. In 2021, 745 Oregonians died from opioid overdoses, up from 472 deaths in 2020 and 280 in 2019. The money received in these settlements is shared between local governments and the state-wide Opioid Settlement Prevention Treatment and Recovery Board. The funds will be used to combat the opioid epidemic and prevent and treat substance-use disorders.

“The damage done to families, communities, to our state and our country can never be undone, but we can hold those at fault accountable and make them help pay the costs associated with Oregon’s response to the crisis,” said AG Rosenblum.  “I want to thank the county and city governments who joined us in these settlements and helped maximize Oregon’s total recovery.”

Oregon’s opioid settlement agreements:

The settlements also provide for significant injunctive relief that, among other things, prohibits Teva from promoting opioids and bans Allergan from selling opioid for at least 10 years. CVS and Walgreens are required to monitor, report, and share data about suspicious activity related to opioid prescriptions. This court-ordered injunctive relief will help ensure a crisis like this does not happen again.

Recently Published by The Skanner News

  • Default
  • Title
  • Date
  • Random